Recombinant Rhesus Macaque REG1B Protein (HEK293)，hFc

REG1B (Regenerating islet-derived 1 beta) is a member of the Reg family of proteins, which are known to play significant roles in regenerative processes, particularly in the context of pancreatic islet cells. Research has shown that REG1B is involved in the regulation of cell proliferation and differentiation, making it a key candidate for studying diabetic conditions and islet regeneration. Elevated expressions of REG1B have been observed in various tumors, suggesting its potential role in oncogenesis and the tumor microenvironment. Furthermore, REG1B’s involvement in inflammatory responses and its secretion by certain cell types underline its dual role in both regeneration and pathology. Understanding the molecular mechanisms of REG1B can provide insights into therapeutic strategies for diabetes mellitus and cancer. Recent studies have employed advanced techniques such as recombinant protein analysis, monoclonal antibody generation, and bioinformatics to elucidate REG1B’s structure and function, paving the way for targeted drug design and regenerative medicine applications. Overall, REG1B represents a fascinating area of research with promising implications for both diabetes treatment and cancer therapy, highlighting the complex interplay between regeneration and disease.